EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.

Shared hematopoietic progenitor cells can give rise to distinct CLL clones with different genetic features in humans, as shown in two transplant siblings.

• Why it matters: Understanding the origin of CLL is crucial for developing targeted therapies and improving disease management, especially when clones arise from common precursors but diverge genetically.
• What they did: The study examined two siblings who developed CLL after transplantation, analyzing their clones for IG gene rearrangements and genomic aberrations, revealing both shared and distinct mutations.
• The result: Findings indicate that CLL can originate from hematopoietic progenitors, with shared mutations in MED12 and NOTCH1 suggesting pathway involvement, which may influence disease predisposition and progression.